Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer

Zheng Jian,Yichao Han,Wentian Zhang,Chengqiang Li,Wei Guo,Xijia Feng,Bin Li,Hecheng Li

DOI: https://doi.org/10.1186/s13578-022-00855-x

2022-08-22

Abstract:PI3K-Akt pathway activation and the expression of histone deacetylases (HDACs) are highly increased in esophageal cancer, suggesting that inhibition of such targets may be a viable therapeutic strategy. Herein, we aimed to evaluate the anti-tumor effect of CUDC-907, a dual PI3K-HDAC inhibitor, in esophageal squamous cell carcinoma (ESCC).

biochemistry & molecular biology